Mary C. Fulbright

441 citations
14 papers · 260 indexed · h-index 7
Topics
Myeloproliferative Neoplasms: Diagnosis and Treatment (11 papers)Acute Myeloid Leukemia Research (8 papers)Kruppel-like factors research (4 papers)

In The Last Decade

Mary C. Fulbright

13 papers receiving 258 citations

Peers

Mary C. Fulbright
Comparison fields: 5 of 51
  • Molecular Biology 192
  • Genetics 95
  • Hematology 79
  • Rheumatology 31
  • Oncology 23
Replace Juergen Fink with:
Juergen Fink United Kingdom
Sebastiano Rontauroli Italy
Valentina Artusi Italy
Chi Ly Australia
Zelia Prudente Italy
Alessandra Audia United States
Juliana Xavier-Ferrucio United States
Nerea Marcotegui Spain
Hélène Lelièvre France
Yung Hwang United States
Mary C. Fulbright relative to Juergen Fink United Kingdom Juergen Fink's profile →
Citations per field
00.5×1.5×
Juergen Fink · 1×
Citations per year

Countries citing papers authored by Mary C. Fulbright

Since Specialization
Citations

This map shows the geographic impact of Mary C. Fulbright's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mary C. Fulbright with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mary C. Fulbright more than expected).

Fields of papers citing papers by Mary C. Fulbright

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mary C. Fulbright. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mary C. Fulbright. The network helps show where Mary C. Fulbright may publish in the future.

Co-authorship network of co-authors of Mary C. Fulbright

This figure shows the co-authorship network connecting the top 25 collaborators of Mary C. Fulbright. A scholar is included among the top collaborators of Mary C. Fulbright based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mary C. Fulbright. Mary C. Fulbright is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
#WorkIndexed citations
1 1
2 7
3 1
4 1
5 15
6 2
7 25
8 12
9 2
10 70
11 46
12 1
13 0
14 77

About Mary C. Fulbright

Mary C. Fulbright is a scholar working on Genetics, Hematology and Molecular Biology, having authored 14 papers that have together received 260 indexed citations. Recurring topics across this work include Myeloproliferative Neoplasms: Diagnosis and Treatment (11 papers), Acute Myeloid Leukemia Research (8 papers) and Kruppel-like factors research (4 papers). The work is most often cited by research in Genetics (95 citations), Hematology (79 citations) and Molecular Biology (192 citations). Mary C. Fulbright has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Raphael Kopan, David Piwnica‐Worms, Ma. Xenia G. Ilagan, Stephen T. Oh, Elizabeth K. Engle, Olga Malkova, Amy Zhou, Cathrine A. Miner, Gregory K. Behbehani and Garry P. Nolan. Their work appears in journals such as Journal of Clinical Investigation, Blood and Molecular Cell.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026